SecBot SecBot
8-K ·Filed Oct 21, 2026

IRD

Opus Genetics, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed5d 12h ago SEC0001140361-26-040377
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor the next 10-K for the full separation agreement and any subsequent C-suite changes; this departure appears orderly and pre-planned.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+1d
IRD ▼ -9.16% at T+1d
NEUTRAL call -9.16% · α vs SPY -8.64% · entry $3.82 → $3.47
Next anchor: T+5d tomorrow
Entry = T+0 close
Oct 21, 2026
via day close
T+1d
-9.16%
call -9.16% · α -8.64%
$3.47
settled 5d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 22d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Opus Genetics announced the transition of Chief Scientific and Development Officer Ashwath Jayagopal, effective October 19, 2026, under a six-month consulting arrangement at $250/hour. This is a routine C-suite departure with a transition plan in place, no red flags such as termination or resignation without replacement.

Key Facts

  • Ashwath Jayagopal transitions from Chief Scientific and Development Officer effective October 19, 2026
  • Six-month consulting agreement at $250 per hour for transition services
  • Outstanding vested options remain exercisable during consulting term
  • No replacement named; CEO George Magrath remains in place

Financial Impact

Consulting cost of $250/hour for up to six months; immaterial relative to company financials

Risk Factors

  • Loss of key scientific leadership could slow pipeline progress if transition is not smooth
  • No permanent replacement announced may signal difficulty in attracting talent

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-040377
Document: 0001140361-26-040377-index-headers.html0001140361-26-040377
Document: 0001140361-26-040377-index.html0001140361-26-040377
Document: 0001140361-26-040377.txt0001140361-26-040377
25 reports for IRD
Performance horizon
50% Hit rate @ T+60 2 of 4 directional calls Went positive at some point 5 of 8 best @ T+60▲ +28.19%May 12, 2026
Filters
Rows
Reports for IRD — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
144
NEUTRAL ★ 2/10
$3.52awaiting T+60—$3.32 (−5.68%)
Oct 21, 2026
5d ago
8-K
NEUTRAL ★ 2/10
$3.82awaiting T+60—$3.32 (−13.09%)
Oct 15, 2026
11d ago
8-K
BULLISH ★ 6/10
$3.84awaiting T+60—$3.32 (−13.54%)
Oct 15, 2026
11d ago
Press Release
BULLISH ★ 6/10
$3.84awaiting T+60—$3.32 (−13.54%)
Sep 22, 2026
4w ago
Institutional Cluster
NEUTRAL ★ 3/10
$5.16awaiting T+60—$3.32 (−35.66%)
Sep 11, 2026
6w ago
8-K
BULLISH ★ 7/10
$6.04awaiting T+60—$3.32 (−45.03%)
Sep 9, 2026
6w ago
8-K
BULLISH ★ 7/10
$5.73awaiting T+60—$3.32 (−42.06%)
Sep 2, 2026
7w ago
Press Release
NEUTRAL ★ 5/10
$4.45awaiting T+60—$3.32 (−25.39%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$3.72awaiting T+60—$3.32 (−10.75%)
Jul 23, 2026
13w ago
144
NEUTRAL ★ 2/10
$2.92 $4.05▲ +38.70%▲ +34.15%$3.32 (+13.70%)
Showing 10 of 25

US Market Status

Market Closed — Opens in 5h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 21, 2026